+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biosimilars And Biosuperiors Market Research Reports

Biosimilar Interleukins Global Market Report 2024 - Product Thumbnail Image

Biosimilar Interleukins Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Biosimilar Lymphocyte Modulator Global Market Report 2024 - Product Thumbnail Image

Biosimilar Lymphocyte Modulator Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Biosimilar Growth Hormones Global Market Report 2024 - Product Thumbnail Image

Biosimilar Growth Hormones Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Insulin biosimilars Global Market Report 2024 - Product Thumbnail Image

Insulin biosimilars Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Biologic & Biosimilar RA Drugs Global Market Report 2024 - Product Thumbnail Image

Biologic & Biosimilar RA Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Biosimilars: Global Strategic Business Report - Product Thumbnail Image

Biosimilars: Global Strategic Business Report

  • Report
  • April 2024
  • 193 Pages
  • Global
From
From
From
From
From
From
From
From
Global Generic And Biosimilar Pharmaceuticals - Industry Report - Product Thumbnail Image

Global Generic And Biosimilar Pharmaceuticals - Industry Report

  • Report
  • April 2024
  • 1130 Pages
  • Global
From
Thematic Intelligence - Biosimilars in oncology - Product Thumbnail Image

Thematic Intelligence - Biosimilars in oncology

  • Report
  • December 2023
  • 76 Pages
  • Global
From
Loading Indicator

The Biosimilars and Biosuperiors market is a rapidly growing sector of the pharmaceutical industry. Biosimilars are biologic drugs that are highly similar to an existing biologic drug, while biosuperiors are biologic drugs that are more effective than an existing biologic drug. Biosimilars and biosuperiors are used to treat a variety of conditions, including cancer, autoimmune diseases, and inflammatory diseases. Biosimilars and biosuperiors are developed using advanced biotechnology techniques, such as recombinant DNA technology and monoclonal antibody technology. These drugs are designed to be more cost-effective than their original counterparts, while still providing the same therapeutic benefits. The Biosimilars and Biosuperiors market is expected to continue to grow in the coming years, as more biologic drugs are developed and approved for use. Companies in this market include Amgen, Pfizer, Merck, and Novartis. Show Less Read more